Fresenius Consolidated Income from 2010 to 2024

FMS Stock  USD 18.97  0.37  1.99%   
Check Fresenius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fresenius main balance sheet or income statement drivers, such as Interest Expense of 234.9 M, Total Revenue of 11.4 B or Gross Profit of 3.7 B, as well as many exotic indicators such as Price To Sales Ratio of 0.28, Dividend Yield of 0.0612 or PTB Ratio of 0.39. Fresenius financial statements analysis is a perfect complement when working with Fresenius Medical Valuation or Volatility modules.
  
This module can also supplement Fresenius Medical's financial leverage analysis and stock options assessment as well as various Fresenius Medical Technical models . Check out the analysis of Fresenius Medical Correlation against competitors.

About Fresenius Medical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Fresenius Medical income statement, its balance sheet, and the statement of cash flows. Fresenius Medical investors use historical funamental indicators, such as Fresenius Medical's Consolidated Income, to determine how well the company is positioned to perform in the future. Although Fresenius Medical investors may use each financial statement separately, they are all related. The changes in Fresenius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Fresenius Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Fresenius Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Fresenius Medical. Please read more on our technical analysis and fundamental analysis pages.
KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Fresenius Medical is traded on New York Stock Exchange in the United States.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Fresenius Medical Care is a strong investment it is important to analyze Fresenius Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fresenius Medical's future performance. For an informed investment choice regarding Fresenius Stock, refer to the following important reports:
Check out the analysis of Fresenius Medical Correlation against competitors.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Fresenius Stock analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bonds Directory
Find actively traded corporate debentures issued by US companies
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Is Fresenius Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fresenius Medical. If investors know Fresenius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fresenius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.353
Dividend Share
1.19
Earnings Share
0.91
Revenue Per Share
33.1505
Quarterly Revenue Growth
(0)
The market value of Fresenius Medical Care is measured differently than its book value, which is the value of Fresenius that is recorded on the company's balance sheet. Investors also form their own opinion of Fresenius Medical's value that differs from its market value or its book value, called intrinsic value, which is Fresenius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fresenius Medical's market value can be influenced by many factors that don't directly affect Fresenius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fresenius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fresenius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fresenius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.